| 1 |
33297669 |
10.3324/haematol.2020.267294 |
2022 |
Phenogenomic heterogeneity of post-transplant plasmablastic lymphomas. |
STAT3 |
| 2 |
33579790 |
10.1136/gutjnl-2020-322935 |
2022 |
Oncogenetic landscape of lymphomagenesis in coeliac disease. |
STAT3 |
| 3 |
33944901 |
10.1093/asj/sjab215 |
2022 |
Nonmalignant CD30+ Cells in Contralateral Peri-Implant Capsule of Patient With BIA-ALCL: A Premalignant Step? |
STAT3 |
| 4 |
34380908 |
10.4103/1673-5374.320991 |
2022 |
Krüppel-like factor 7 attenuates hippocampal neuronal injury after traumatic brain injury. |
STAT3 |
| 5 |
34503423 |
10.2174/1871520621666210908103306 |
2022 |
The Acetyltransferase KAT5 Inhibitor NU 9056 Promotes Apoptosis and Inhibits JAK2/STAT3 Pathway in Extranodal NK/T Cell Lymphoma. |
STAT3 |
| 6 |
34520436 |
10.1097/CAD.0000000000001249 |
2022 |
Sensitivity of eight types of ALK fusion variant to alectinib in ALK-transformed cells. |
STAT3 |
| 7 |
34528236 |
10.1111/bjd.20760 |
2022 |
Transcriptomic changes during stage progression of mycosis fungoides. |
STAT3 |
| 8 |
34587248 |
10.1182/blood.2021012976 |
2022 |
Genome-wide CRISPR-Cas9 screen identifies rationally designed combination therapies for CRLF2-rearranged Ph-like ALL. |
STAT3 |
| 9 |
34657149 |
10.1182/blood.2020008136 |
2022 |
Tyrosine phosphatases regulate resistance to ALK inhibitors in ALK+ anaplastic large cell lymphoma. |
STAT3 |
| 10 |
34687742 |
10.1016/j.jid.2021.09.024 |
2022 |
PLCγ1/PKCθ Downstream Signaling Controls Cutaneous T-Cell Lymphoma Development and Progression. |
STAT3 |
| 11 |
34714908 |
10.1182/bloodadvances.2021005486 |
2022 |
Integrative genomic and transcriptomic analysis in plasmablastic lymphoma identifies disruption of key regulatory pathways. |
STAT3 |
| 12 |
34743203 |
10.1038/s41418-021-00880-2 |
2022 |
Glycoprotein PTGDS promotes tumorigenesis of diffuse large B-cell lymphoma by MYH9-mediated regulation of Wnt-β-catenin-STAT3 signaling. |
STAT3 |
| 13 |
34818414 |
10.1182/blood.2021012734 |
2022 |
Genome-wide CRISPR screen identifies CDK6 as a therapeutic target in adult T-cell leukemia/lymphoma. |
STAT3 |
| 14 |
34862350 |
10.1097/MPH.0000000000002364 |
2022 |
Management of Peripheral T-Cell Lymphoma in Children and Adolescents Including STAT 3 Mutation Hyper-IgE Syndrome: One Size Does Not Fit All. |
STAT3 |
| 15 |
34915482 |
10.1159/000521445 |
2022 |
STAT3 Promotes Cell Proliferation by Potentiating the CCL4 Transcriptional Activity in Diffuse Large B-Cell Lymphoma. |
STAT3 |
| 16 |
34917911 |
10.1016/j.jhepr.2021.100386 |
2022 |
ROCK2 inhibition attenuates profibrogenic immune cell function to reverse thioacetamide-induced liver fibrosis. |
STAT3 |
| 17 |
34922904 |
10.1016/j.cbi.2021.109779 |
2022 |
Diffuse large B-cell lymphoma-derived exosomes push macrophage polarization toward M2 phenotype via GP130/STAT3 signaling pathway. |
STAT3 |
| 18 |
34977845 |
10.1016/j.xjidi.2021.100068 |
2022 |
Genomic Analysis of Cutaneous CD30-Positive Lymphoproliferative Disorders. |
STAT3 |
| 19 |
35014680 |
10.3892/mmr.2022.12592 |
2022 |
Role of TGM2 in T‑cell lymphoblastic lymphoma via regulation of IL‑6/JAK/STAT3 signalling. |
STAT3 |
| 20 |
35021606 |
10.3324/haematol.2021.280003 |
2022 |
Immune pathway upregulation and lower genomic instability distinguish EBV-positive nodal T/NK-cell lymphoma from ENKTL and PTCL-NOS. |
STAT3 |
| 21 |
35059947 |
10.1007/s10875-021-01197-y |
2022 |
Malignancy in STAT3 Deficient Hyper IgE Syndrome. |
STAT3 |
| 22 |
35085771 |
10.1016/j.cellsig.2022.110264 |
2022 |
EML4-ALK G1202R mutation induces EMT and confers resistance to ceritinib in NSCLC cells via activation of STAT3/Slug signaling. |
STAT3 |
| 23 |
35100463 |
10.1111/cas.15277 |
2022 |
Inhibition of adult T-cell leukemia cell proliferation by polymerized proanthocyanidin from blueberry leaves through JAK proteolysis. |
STAT3 |
| 24 |
35133054 |
10.1111/cas.15296 |
2022 |
Downregulation of miR-26 promotes invasion and metastasis via targeting interleukin-22 in cutaneous T-cell lymphoma. |
STAT3 |
| 25 |
35136485 |
10.18632/oncotarget.28189 |
2022 |
GZ17-6.02 and axitinib interact to kill renal carcinoma cells. |
STAT3 |
| 26 |
35189357 |
10.1016/j.phrs.2022.106134 |
2022 |
Expanding the armory for treating lymphoma: Targeting redox cellular status through thioredoxin reductase inhibition. |
STAT3 |
| 27 |
35199089 |
10.1016/j.xjidi.2021.100084 |
2022 |
Malignant T Cell Activation by a <i>Bacillus</i> Species Isolated from Cutaneous T-Cell Lymphoma Lesions. |
STAT3 |
| 28 |
35228642 |
10.1038/s41698-022-00254-y |
2022 |
STAT3 inhibition suppresses adaptive survival of ALK-rearranged lung cancer cells through transcriptional modulation of apoptosis. |
STAT3 |
| 29 |
35249489 |
10.2174/1568009622666220304202116 |
2022 |
Novel Compound, ND-17, Regulates the JAK/STAT, PI3K/AKT, and MAPK Pathways and Restrains Human T-lymphoid Leukemia Development. |
STAT3 |
| 30 |
35279012 |
10.1016/j.biopha.2022.112800 |
2022 |
The multifaceted mechanisms of Paeoniflorin in the treatment of tumors: State-of-the-Art. |
STAT3 |
| 31 |
35340094 |
10.1111/vco.12816 |
2022 |
Anticancer activity of IRAK-4 inhibitors against canine lymphoid malignancies. |
STAT3 |
| 32 |
35359405 |
10.3389/fonc.2022.842356 |
2022 |
Fbw7 Inhibits the Progression of Activated B-Cell Like Diffuse Large B-Cell Lymphoma by Targeting the Positive Feedback Loop of the LDHA/lactate/miR-223 Axis. |
STAT3 |
| 33 |
35366115 |
10.1007/s00428-022-03309-4 |
2022 |
Cutaneous presentation of enteropathy-associated T-cell lymphoma masquerading as a DUSP22-rearranged CD30+ lymphoproliferation. |
STAT3 |
| 34 |
35395970 |
10.19746/j.cnki.issn.1009-2137.2022.02.013 |
2022 |
[Expression Level of SOCS3 in Acute Lymphoblastic Leukemia Cells Affects the Cytotoxicity of NK Cells]. |
STAT3 |
| 35 |
35411036 |
10.1038/s41388-022-02301-1 |
2022 |
Novel TENM3-ALK fusion is an alternate mechanism for ALK activation in neuroblastoma. |
STAT3 |
| 36 |
35438417 |
10.1007/s10875-022-01269-7 |
2022 |
Correction to: Malignancy in STAT3 Deficient Hyper IgE Syndrome. |
STAT3 |
| 37 |
35439335 |
10.1002/hon.3007 |
2022 |
The potential efficacy and mechanism of bendamustine in entra-nodal NK/T cell lymphoma. |
STAT3 |
| 38 |
35474053 |
10.1007/s11033-022-07399-w |
2022 |
STAT signaling as a target for intervention: from cancer inflammation and angiogenesis to non-coding RNAs modulation. |
STAT3 |
| 39 |
35477814 |
10.1007/s10637-022-01250-6 |
2022 |
Exportin-1 is critical for cell proliferation and survival in adult T cell leukemia. |
STAT3 |
| 40 |
35484662 |
10.3324/haematol.2021.279957 |
2022 |
Resistance to PI3κδ inhibitors in marginal zone lymphoma can be reverted by targeting the IL-6/PDGFRA axis. |
STAT3 |
| 41 |
35489748 |
10.21873/anticanres.15709 |
2022 |
Dimethyl Fumarate Induces Apoptosis <i>via</i> Inhibiting NF-κB and STAT3 Signaling in Adult T-cell Leukemia/Lymphoma Cells. |
STAT3 |
| 42 |
35501257 |
10.1016/j.clml.2022.04.002 |
2022 |
Indolent Lymphoproliferative T-Cell Disorders Associated With Gastrointestional Disease: Diagnostic Challenges and Outcomes. |
STAT3 |
| 43 |
35557592 |
10.21037/jgo-22-237 |
2022 |
miRNA-320 inhibits colitis-associated colorectal cancer by regulating the IL-6R/STAT3 pathway in mice. |
STAT3 |
| 44 |
35578798 |
10.1002/jcp.30777 |
2022 |
Neddylation inactivation affects cell cycle and apoptosis in sheep follicular granulosa cells. |
STAT3 |
| 45 |
35579082 |
10.1111/cas.15402 |
2022 |
CircPCBP2 promotes the stemness and chemoresistance of DLBCL via targeting miR-33a/b to disinhibit PD-L1. |
STAT3 |
| 46 |
35600392 |
10.3389/fonc.2022.881801 |
2022 |
SOCS3 Acts as an Onco-immunological Biomarker With Value in Assessing the Tumor Microenvironment, Pathological Staging, Histological Subtypes, Therapeutic Effect, and Prognoses of Several Types of Cancer. |
STAT3 |
| 47 |
35640677 |
10.1016/j.ajpath.2022.05.005 |
2022 |
Induction of Transcriptional Inhibitor HES1 and the Related Repression of Tumor-Suppressor TXNIP Are Important Components of Cell-Transformation Program Imposed by Oncogenic Kinase NPM-ALK. |
STAT3 |
| 48 |
35642002 |
10.1186/s12967-022-03451-2 |
2022 |
Role of chemokine-mediated angiogenesis in resistance towards crizotinib and its reversal by anlotinib in EML4-ALK positive NSCLC. |
STAT3 |
| 49 |
35651609 |
10.3389/fimmu.2022.878989 |
2022 |
Hyper-IgE and Carcinoma in CADINS Disease. |
STAT3 |
| 50 |
35671182 |
10.1097/CM9.0000000000001916 |
2022 |
Hepatocyte growth factor protects pulmonary endothelial barrier against oxidative stress and mitochondria-dependent apoptosis. |
STAT3 |
| 51 |
35697790 |
10.1038/s41375-022-01623-z |
2022 |
Genomic profiling identifies distinct genetic subtypes in extra-nodal natural killer/T-cell lymphoma. |
STAT3 |
| 52 |
35743211 |
10.3390/ijms23126773 |
2022 |
Mechanisms of Sensitivity and Resistance of Primary Effusion Lymphoma to Dimethyl Fumarate (DMF). |
STAT3 |
| 53 |
35752777 |
10.1186/s12860-022-00422-9 |
2022 |
Evaluation of the putative lymphoma-associated point mutation D427H in the STAT3 transcription factor. |
STAT3 |
| 54 |
35790291 |
10.21873/anticanres.15823 |
2022 |
SOCS1 Gene Therapy for Head and Neck Cancers: An Experimental Study. |
STAT3 |
| 55 |
35803438 |
10.1016/j.taap.2022.116156 |
2022 |
1-(4-((5-chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimidin-2-yl)amino)-3-methoxyphenyl)-3-(2-(dimethylamino)ethyl)imidazolidin-2-one (ZX-42) inhibits cell proliferation and induces apoptosis via inhibiting ALK and its downstream pathways in Karpas299 cells. |
STAT3 |
| 56 |
35805156 |
10.3390/cells11132072 |
2022 |
Phospho-Specific Flow Cytometry Reveals Signaling Heterogeneity in T-Cell Acute Lymphoblastic Leukemia Cell Lines. |
STAT3 |
| 57 |
35879049 |
10.1136/gutjnl-2021-326257 |
2022 |
Immunopathogenesis and environmental triggers in coeliac disease. |
STAT3 |
| 58 |
35882439 |
10.1182/bloodadvances.2022007541 |
2022 |
Genetic and immunohistochemical profiling of NK/T-cell Lymphomas reveals prognostically relevant BCOR-MYC association. |
STAT3 |
| 59 |
35884913 |
10.3390/biomedicines10071608 |
2022 |
Downregulation of STAT3 in Epstein-Barr Virus-Positive Hodgkin Lymphoma. |
STAT3 |
| 60 |
35897737 |
10.3390/ijms23158161 |
2022 |
The Pt(<i>S</i>-pr-thiosal)2 and BCL1 Leukemia Lymphoma: Antitumor Activity In Vitro and In Vivo. |
STAT3 |
| 61 |
35903524 |
10.1016/j.jsps.2022.05.009 |
2022 |
Genistein promotes M1 macrophage apoptosis and reduces inflammatory response by disrupting miR-21/TIPE2 pathway. |
STAT3 |
| 62 |
35917766 |
10.1016/j.bmc.2022.116936 |
2022 |
Design, synthesis and in vitro biological evaluation of marine phidianidine derivatives as potential anti-inflammatory agents. |
STAT3 |
| 63 |
35973920 |
10.1016/j.jcyt.2022.06.007 |
2022 |
Human gingival mesenchymal stem cells improve movement disorders and tyrosine hydroxylase neuronal damage in Parkinson disease rats. |
STAT3 |
| 64 |
35990641 |
10.3389/fimmu.2022.937872 |
2022 |
Genomic crossroads between non-Hodgkin's lymphoma and common variable immunodeficiency. |
STAT3 |
| 65 |
35994220 |
10.1007/s12013-022-01088-y |
2022 |
Effects of STAT3 Inhibitor BP-1-102 on The Proliferation, Invasiveness, Apoptosis and Neurosphere Formation of Glioma Cells in Vitro. |
STAT3 |
| 66 |
36035991 |
10.3389/fcell.2022.935023 |
2022 |
Protein Kinase CK2 represents a new target to boost Ibrutinib and Venetoclax induced cytotoxicity in mantle cell lymphoma. |
STAT3 |
| 67 |
36045346 |
10.1186/s12943-022-01640-7 |
2022 |
PDGFRβ promotes oncogenic progression via STAT3/STAT5 hyperactivation in anaplastic large cell lymphoma. |
STAT3 |
| 68 |
36064579 |
10.1038/s41388-022-02453-0 |
2022 |
ALK fusion promotes metabolic reprogramming of cancer cells by transcriptionally upregulating PFKFB3. |
STAT3 |
| 69 |
36086962 |
10.15586/aei.v50i5.626 |
2022 |
Deoxyelephantopin alleviates lipopolysaccharide-induced septic lung injury through inhibiting NF-ĸB/STAT3 axis. |
STAT3 |
| 70 |
32270320 |
10.1007/s00403-020-02062-5 |
2021 |
The polymorphisms of IL-6/STAT3 signaling pathway may contribute to cutaneous T-cell lymphomas susceptibility. |
STAT3 |
| 71 |
32273478 |
10.3324/haematol.2020.251579 |
2021 |
Genetic lesions in MYC and STAT3 drive oncogenic transcription factor overexpression in plasmablastic lymphoma. |
STAT3 |
| 72 |
32327503 |
10.3324/haematol.2019.238766 |
2021 |
Whole Exome Sequencing reveals NOTCH1 mutations in anaplastic large cell lymphoma and points to Notch both as a key pathway and a potential therapeutic target. |
STAT3 |
| 73 |
32619110 |
10.1080/10520295.2020.1770332 |
2021 |
Silencing Stat3 inhibits viability and induces apoptosis in BGC-823 human gastric cancer cell line. |
STAT3 |
| 74 |
32780548 |
10.1111/cbdd.13778 |
2021 |
Alantolactone induces apoptosis in THP-1 cells through STAT3, survivin inhibition, and intrinsic apoptosis pathway. |
STAT3 |
| 75 |
32822082 |
10.1002/ptr.6842 |
2021 |
MicroRNA216b mediated downregulation of HSP27/STAT3/AKT signaling is critically involved in lambertianic acid induced apoptosis in human cervical cancers. |
STAT3 |
| 76 |
32961552 |
10.1182/blood.2020007507 |
2021 |
Mutational landscape of gray zone lymphoma. |
STAT3 |
| 77 |
32985300 |
10.1080/10428194.2020.1817431 |
2021 |
Increased myeloid-derived suppressor cells in patients with myelodysplastic syndromes suppress CD8+ T lymphocyte function through the STAT3-ARG1 pathway. |
STAT3 |
| 78 |
33079297 |
10.1007/s10014-020-00386-8 |
2021 |
Clinicopathologic significance of MYD88 L265P mutation and expression of TLR4 and P-STAT3 in primary central nervous system diffuse large B-cell lymphomas. |
STAT3 |
| 79 |
33080566 |
10.1016/j.phymed.2020.153366 |
2021 |
Effect of the isoflavone corylin from cullen corylifolium on colorectal cancer growth, by targeting the STAT3 signaling pathway. |
STAT3 |
| 80 |
33158639 |
10.1016/j.ejso.2020.10.029 |
2021 |
Biological and genetic landscape of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). |
STAT3 |
| 81 |
33184494 |
10.1038/s41375-020-01088-y |
2021 |
A novel model of alternative NF-κB pathway activation in anaplastic large cell lymphoma. |
STAT3 |
| 82 |
33223115 |
10.1016/j.jep.2020.113514 |
2021 |
Ethyl acetate extract of Tibetan medicine Rhamnella gilgitica ameliorated type II collagen-induced arthritis in rats via regulating JAK-STAT signaling pathway. |
STAT3 |
| 83 |
33247178 |
10.1038/s41375-020-01093-1 |
2021 |
STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma. |
STAT3 |
| 84 |
33247999 |
10.1111/cas.14752 |
2021 |
Interleukin 6 regulates the expression of programmed cell death ligand 1 in thyroid cancer. |
STAT3 |
| 85 |
33307035 |
10.1016/j.ajpath.2020.12.001 |
2021 |
PIM Kinases Promote Survival and Immune Escape in Primary Mediastinal Large B-Cell Lymphoma through Modulation of JAK-STAT and NF-κB Activity. |
STAT3 |
| 86 |
33310759 |
10.26508/lsa.202000794 |
2021 |
Requirement of DNMT1 to orchestrate epigenomic reprogramming for NPM-ALK-driven lymphomagenesis. |
STAT3 |
| 87 |
33333215 |
10.1016/j.gene.2020.145354 |
2021 |
Puerarin alleviates coronary heart disease via suppressing inflammation in a rat model. |
STAT3 |
| 88 |
33367520 |
10.1093/asj/sjaa398 |
2021 |
Analysis of the Molecular Signature of Breast Implant-Associated Anaplastic Large Cell Lymphoma in an Asian Patient. |
STAT3 |
| 89 |
33370049 |
10.1097/PRS.0000000000007423 |
2021 |
Cellular and Molecular Mechanisms of Breast Implant-Associated Anaplastic Large Cell Lymphoma. |
STAT3 |
| 90 |
33389078 |
10.1007/s00432-020-03446-w |
2021 |
Vincristine upregulates PD-L1 and increases the efficacy of PD-L1 blockade therapy in diffuse large B-cell lymphoma. |
STAT3 |
| 91 |
33393492 |
10.1172/JCI142627 |
2021 |
Doubling up on function: dual-specificity tyrosine-regulated kinase 1A (DYRK1A) in B cell acute lymphoblastic leukemia. |
STAT3 |
| 92 |
33393494 |
10.1172/JCI135937 |
2021 |
DYRK1A regulates B cell acute lymphoblastic leukemia through phosphorylation of FOXO1 and STAT3. |
STAT3 |
| 93 |
33410350 |
10.1080/10428194.2020.1869964 |
2021 |
<i>STAT3</i> and <i>STAT5B</i> mutations have unique distribution in T-cell large granular lymphocyte proliferations and advanced myeloid neoplasms. |
STAT3 |
| 94 |
33418509 |
10.1016/j.ebiom.2020.103191 |
2021 |
Dnmt3b catalytic activity is critical for its tumour suppressor function in lymphomagenesis and is associated with c-Met oncogenic signalling. |
STAT3 |
| 95 |
33466582 |
10.3390/cancers13020280 |
2021 |
JAK3 Is Expressed in the Nucleus of Malignant T Cells in Cutaneous T Cell Lymphoma (CTCL). |
STAT3 |
| 96 |
33512408 |
10.1182/blood.2020005964 |
2021 |
TLR9 expression in chronic lymphocytic leukemia identifies a promigratory subpopulation and novel therapeutic target. |
STAT3 |
| 97 |
33512451 |
10.1182/blood.2020006721 |
2021 |
Linking the KIR phenotype with STAT3 and TET2 mutations to identify chronic lymphoproliferative disorders of NK cells. |
STAT3 |
| 98 |
33513694 |
10.3390/biomedicines9020118 |
2021 |
IRE1 Alpha/XBP1 Axis Sustains Primary Effusion Lymphoma Cell Survival by Promoting Cytokine Release and STAT3 Activation. |
STAT3 |
| 99 |
33529679 |
10.1016/j.fct.2021.112031 |
2021 |
Methylgerambullin derived from plant Glyccsmis pentaphylla (Retz) correa. Mediates anti-hepatocellular carcinoma cancer effect by activating mitochondrial and endoplasmic reticulum stress signaling and inhibiting AKT and STAT3 pathways. |
STAT3 |
| 100 |
33544565 |
10.1097/PAS.0000000000001658 |
2021 |
Immunophenotypic Spectrum and Genomic Landscape of Refractory Celiac Disease Type II. |
STAT3 |
Datasets
Models
